DocGo Inc. (NASDAQ:DCGO) Short Interest Update

DocGo Inc. (NASDAQ:DCGO) saw a significant growth in short interest in the month of February. As of February 28th, there was short interest totalling 7,710,000 shares, a growth of 17.5% from the February 13th total of 6,560,000 shares. Currently, 8.8% of the company’s shares are short sold. Based on an average trading volume of 759,000 shares, the short-interest ratio is presently 10.2 days.

DocGo Trading Down 0.5 %

NASDAQ DCGO traded down $0.02 during trading hours on Wednesday, reaching $2.83. The company’s stock had a trading volume of 457,765 shares, compared to its average volume of 744,331. The business has a 50-day simple moving average of $4.26 and a 200 day simple moving average of $3.97. DocGo has a 52 week low of $2.75 and a 52 week high of $5.68. The stock has a market cap of $288.10 million, a PE ratio of 10.09, a PEG ratio of 14.16 and a beta of 1.08.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Centiva Capital LP acquired a new position in DocGo in the 3rd quarter worth approximately $43,000. Summit Investment Advisors Inc. raised its holdings in shares of DocGo by 38.7% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after purchasing an additional 2,968 shares in the last quarter. Prudential Financial Inc. bought a new position in shares of DocGo during the 4th quarter valued at $55,000. Intech Investment Management LLC bought a new position in shares of DocGo in the third quarter worth about $62,000. Finally, Royce & Associates LP bought a new stake in shares of DocGo in the fourth quarter valued at approximately $64,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on DCGO. Needham & Company LLC decreased their price target on DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a research note on Friday, February 28th. Stifel Nicolaus dropped their price objective on DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Finally, Deutsche Bank Aktiengesellschaft lowered DocGo from a “buy” rating to a “hold” rating and lowered their price target for the stock from $5.00 to $2.85 in a report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $4.89.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.